NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 209 filers reported holding NOVAVAX INC in Q4 2023. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $760 | -86.0% | 60 | -94.7% | 0.00% | -100.0% |
| Q1 2024 | $5,411 | -38.5% | 1,132 | -38.2% | 0.00% | -33.3% |
| Q4 2023 | $8,794 | +138.2% | 1,832 | +259.2% | 0.00% | +50.0% |
| Q3 2023 | $3,692 | +787.5% | 510 | +750.0% | 0.00% | – |
| Q2 2023 | $416 | – | 60 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 60 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $1 | -99.9% | 60 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,000 | -66.7% | 60 | 0.0% | 0.00% | -75.0% |
| Q2 2022 | $3,000 | -25.0% | 60 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $4,000 | -55.6% | 60 | 0.0% | 0.00% | -60.0% |
| Q4 2021 | $9,000 | -25.0% | 60 | 0.0% | 0.01% | -33.3% |
| Q3 2021 | $12,000 | -7.7% | 60 | 0.0% | 0.02% | -6.2% |
| Q2 2021 | $13,000 | +18.2% | 60 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $11,000 | +57.1% | 60 | 0.0% | 0.02% | +33.3% |
| Q4 2020 | $7,000 | 0.0% | 60 | 0.0% | 0.01% | -7.7% |
| Q3 2020 | $7,000 | – | 60 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,002,087 | $544,308,000 | 8.21% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 323,517 | $58,657,000 | 7.86% |
| Samsara BioCapital, LLC | 198,600 | $36,008,000 | 6.64% |
| Foresite Capital Management I, LLC | 66,810 | $12,113,000 | 6.11% |
| Foresite Capital Management II, LLC | 67,373 | $12,215,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 191,200 | $34,666,000 | 2.63% |
| Rock Springs Capital Management LP | 461,000 | $83,584,000 | 1.82% |
| TSP Capital Management Group, LLC | 23,525 | $4,265,000 | 1.50% |
| Ikarian Capital, LLC | 195,700 | $35,483,000 | 1.19% |
| SevenOneSeven Capital Management | 1,744 | $316,000 | 1.16% |